Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: A meta-analysis

Gene

Volumn 525, Issue 1, 2013, Pages 92-98

  He, Bangshun ^a   Xu, Yeqiong ^a   Pan, Yuqin ^a   Li, Rui ^b   Gao, Tianyi ^a   Song, Guoqi ^c   Gu, Ling ^b   Nie, Zhenlin ^a   Chen, Liping ^b   Wang, Shukui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Breast cancer; IGF1; Meta analysis; Polymorphism

Indexed keywords

SOMATOMEDIN C;

ADULT; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; ETHNICITY; FEMALE; GENE; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IGF1 GENE; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; DINUCLEOTIDE REPEATS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS;

EID: 84878839962     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.041     Document Type: Article

References (42)

1. Al-Ajmi K., Ganguly S.S., Al-Ajmi A., Mandhari Z.A., Al-Moundhri M.S. Insulin-like growth factor 1 gene polymorphism and breast cancer risk among Arab Omani women: a case-control study. Breast Cancer (Auckl) 2012, 6:103-112.
2. Cleveland R.J., et al. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 2006, 27:758-765.
3. DeLellis K., et al. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br. J. Cancer 2003, 88:277-282.
4. D'Ercole A.J. Insulin-like growth factors and their receptors in growth. Endocrinol. Metab. Clin. North Am. 1996, 25:573-590.
5. Dunn S.E., Hardman R.A., Kari F.W., Barrett J.C. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 1997, 57:2687-2693.
6. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
7. Figer A., et al. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr. Med. Assoc. J. 2002, 4:759-762.
8. Gebhardt F., Zanker K.S., Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J. Biol. Chem. 1999, 274:13176-13180.
9. Gockerman A., Prevette T., Jones J.I., Clemmons D.R. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 1995, 136:4168-4173.
10. Gonzalez-Zuloeta Ladd A.M., et al. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women. Eur. J. Cancer 2007, 43:1718-1722.
11. Hankinson S.E., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998, 351:1393-1396.
12. Harrela M., et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J. Clin. Invest. 1996, 98:2612-2615.
13. Jackson J.G., White M.F., Yee D. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J. Biol. Chem. 1998, 273:9994-10003.
14. Jernstrom H., Barrett-Connor E. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study. J. Womens Health Gend. Based Med. 1999, 8:1265-1272.
15. Jernstrom H., et al. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol. Genet. Metab. 2001, 72:144-154.
16. Jernstrom H., et al. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol. Biomarkers Prev. 2001, 10:377-384.
17. Kao P.C., Matheny A.P., Lang C.A. Insulin-like growth factor-I comparisons in healthy twin children. J. Clin. Endocrinol. Metab. 1994, 78:310-312.
18. Laban C., Bustin S.A., Jenkins P.J. The GH-IGF-I axis and breast cancer. Trends Endocrinol. Metab. 2003, 14:28-34.
19. Lee A.V., et al. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol. 1999, 13:787-796.
20. Lee S., Medina D., et al. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res. 2006, 8:R6.
21. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
22. Missmer S.A., et al. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int. J. Cancer 2002, 100:332-336.
23. Nam R.K., et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1429-1437.
24. Petridou E., et al. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control. 2000, 11:383-388.
25. Pollak M.N. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res. Treat. 1998, 47:209-217.
26. Rasmussen A.A., Cullen K.J. Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res. Treat. 1998, 47:219-233.
27. Renehan A.G., et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004, 363:1346-1353.
28. Rietveld I., et al. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur. J. Endocrinol. 2003, 148:171-175.
29. Rietveld I., et al. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin. Endocrinol. (Oxf) 2004, 61:195-203.
30. Rosen C.J., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab. 1998, 83:2286-2290.
31. Rotwein P., Pollock K.M., Didier D.K., Krivi G.G. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J. Biol. Chem. 1986, 261:4828-4832.
32. Sarkissyan M., et al. IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int. J. Oncol. 2011, 38:1663-1673.
33. Slattery M.L., et al. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res. Treat. 2007, 104:197-209.
34. Stewart A.J., Johnson M.D., May F.E., Westley B.R. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 1990, 265:21172-21178.
35. Tae H.J., Luo X., Kim K.H. Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J. Biol. Chem. 1994, 269:10475-10484.
36. Toniolo P., et al. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer 2000, 88:828-832.
37. Vaessen N., et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001, 50:637-642.
38. van den Brandt P.A., et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol. 2000, 152:514-527.
39. Wagner K., et al. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res. Treat. 2005, 92:133-140.
40. Wagner K., Hemminki K., Forsti A. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Res. Treat. 2007, 104:233-248.
41. Wen W., et al. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int. J. Cancer 2005, 113:307-311.
42. Yu H., et al. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res. Treat. 2001, 70:117-122.